Updated Jul 16, 2026
MARAGANORE JOHN has filed 5 SEC Form 4 filings across 5 companies in the last 90 days.
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 3.8K | $0.00 | |
| 2026-05-04 | COAG | Hemab Therapeutics Holdings, Inc. | J — Other acquisition / disposition | 18.0K | — | |
| 2026-05-04 | COAG | Hemab Therapeutics Holdings, Inc. | J — Other acquisition / disposition | 18.0K | — |
MARAGANORE JOHN is a corporate insider — currently tracked as Director of TAKEDA PHARMACEUTICAL CO LTD (TAK). InsiderAlpha tracks every SEC Form 4 filing in real time.
5 primary Form 4 filings in the last 90 days, covering 5 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live MARAGANORE JOHN profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.